High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab.
| Image |  |
|---|---|
| Description | scientific article published on 22 December 2016 |
| Author/s |
author: Joseph Wrin Jennifer E Hardingham |
| Publication date | December 22, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |